Evaluating the analgesic effect and advantage of transcutaneous electrical acupoint stimulation combined with opioid drugs for moderate to severe cancer-related pain: a study protocol for a randomized controlled trial

Abstract

BackgroundTranscutaneous electrical acupoint stimulation (TEAS), which is also known as acupuncture-like transcutaneous electrical nerve stimulation (TENS), has been widely used in acute or chronic pain. However, previous research has not demonstrated that TEAS is effective for cancer-related pain. Opioid drugs are strongly recommended for treating cancer-related pain, but opioid-induced immunosuppression is still the most intractable drug-induced medical problem. Evaluating the efficacy and potential advantage of TEAS combined with opioid drugs in moderate and severe cancer-related pain in China is important because such studies are lacking.Methods/DesignThis trial is a multicenter, prospective randomized controlled clinical trial. In total, 160 patients who were enrolled from two hospitals in the Zhejiang Province (China) will be randomly allocated into two groups: a TEAS group and sham TEAS group without acupoint electrical stimulation. Both groups will receive a 21-day interval of chemotherapy and conventional cancer pain therapy. Fifteen treatment sessions will be performed over a three-week period. The primary outcomes will be measured by changes in the Numerical Rating Scale (NRS) scores and equivalent dosage of morphine at baseline, three weeks of treatment and one two-week follow-up. The secondary outcome measures include cellular immunity function, life quality assessment, opioids side effects assessment, and safety and compliance evaluation.DiscussionThis trial is expected to clarify whether TEAS is effective for cancer-related pain. These results demonstrate the advantage of TEAS combined with opioid drugs on improving immune function and decreasing opioid induced side effects.Trial registrationChinese Clinical Trial Registry, ChiCTR-13003803. Registered on 27 August 2013.Electronic supplementary materialThe online version of this article (10.1186/s13063-018-3145-y) contains supplementary material, which is available to authorized users.

Opioid Prescribing Practices Among Surgical Providers: The Relationship with Patient-Level Factors: Rural Residency or Cancer Diagnosis

“…This contrast in practice and belief may represent an area for improvement and advocacy and warrants further study to determine if underlying bias or sympathy for cancer patients is affecting actual prescribing practices [11]. This is similar to other studies that found that cancer patients were more likely to have an opioid prescription than a non-cancer patient and that they are at high risk for opioid misuse [9][10][11].…”

Effects of transcutaneous electrical acupoint stimulation on perioperative immune function and postoperative analgesia in patients undergoing radical mastectomy: A randomized controlled trial

“…A meta-analysis including a total of 1,350 participants demonstrated that the use of TENS could significantly reduce the consumption of postoperative analgesics ( 42 ), whereas TEAS combined the effect of TENS and acupuncture. In addition, Liang et al ( 43 ) reported that TEAS was an effective adjunct to opioid therapy for moderate and severe cancer-related pain, and could reduce side effects and improve immune function. Therefore, the utilization of TEAS may have a direct clinical application value, especially for patients with cancer.…”

Efficacy and safety of fire-needle in the treatment of gouty arthritis

“…Acupuncture and moxibustion therapy are used as complementary therapy in China and abroad for its effectiveness, simplicity and fewer adverse reactions. Other modifications of acupuncture methods, such as percutaneous electrical stimulation [ 20 ] and electroacupuncture [ 21 ] have been established. The main indication for acupuncture and moxibustion is pain.…”